Gomes Júnior Antonio Luiz, Paz Marcia Fernanda Correia Jardim, da Silva Laís Iasmin Soares, Carvalho Simone da Costa e Silva, Sobral André Luiz Pinho, Machado Kátia da Conceição, Ferreira Paulo Michel Pinheiro, Satyal Prabodh, de Freitas Rivelilson Mendes, Cavalcante Ana Amélia de Carvalho Melo
Laboratory of Genetic Toxicity, Postgraduate Program in Pharmaceutical Sciences, Federal University of Piauí, 64049-550 Teresina, PI, Brazil.
Postgraduate Program in Genetics, State University of São Paulo, 14049-900 Ribeirão Preto, SP, Brazil.
Oxid Med Cell Longev. 2015;2015:212964. doi: 10.1155/2015/212964. Epub 2015 Oct 20.
The aim of this study was to evaluate the oxidative parameters of erythrocytes and genotoxicity in leukocytes of patients with breast cancer. Oxidative parameters were detected by spectrophotometry and genotoxic damage by single cell gel electrophoresis. Twenty-eight women with breast cancer were monitored before chemotherapy and after the second and fourth cycles of therapy with cyclophosphamide and doxorubicin. After the fourth cycle, increases (P < 0.05) in the reactive substances to thiobarbituric acid levels, nitrite content, and superoxide dismutase activity and high rates of DNA damage in leukocytes were observed when compared with healthy women group and baseline levels. Similarly, after the second cycle, the same parameters were increased (P < 0.05) when compared with baseline levels. Increase in catalase activity was detected only after the fourth cycle and reduced glutathione levels and glutathione peroxidase activity were decreased in all cycles when compared with healthy women, as well as after the second and fourth chemotherapy cycles compared to baseline (P < 0.05). Patients with breast cancer presented an indicative of oxidative stress before, during, and after chemotherapy, as well as increased genotoxic damage in all stages of treatment, demonstrating the clinical applicability of this investigation.
本研究的目的是评估乳腺癌患者红细胞的氧化参数和白细胞的遗传毒性。通过分光光度法检测氧化参数,通过单细胞凝胶电泳检测遗传毒性损伤。对28例乳腺癌女性患者在化疗前以及使用环磷酰胺和阿霉素进行第二和第四周期治疗后进行监测。与健康女性组和基线水平相比,在第四周期后,观察到硫代巴比妥酸反应性物质水平、亚硝酸盐含量和超氧化物歧化酶活性增加(P<0.05),白细胞中DNA损伤率较高。同样,与基线水平相比,在第二周期后,相同参数也有所增加(P<0.05)。仅在第四周期后检测到过氧化氢酶活性增加,与健康女性相比,所有周期中还原型谷胱甘肽水平和谷胱甘肽过氧化物酶活性均降低,与基线相比,在第二和第四化疗周期后也降低(P<0.05)。乳腺癌患者在化疗前、化疗期间和化疗后均表现出氧化应激迹象,并且在治疗的所有阶段遗传毒性损伤均增加,证明了本研究的临床适用性。